IL-2 R gamma

IL-2 R gamma Overview

English NameInterleukin-2 receptor subunit gammaApproved Drugs0
Drugs in Clinical Trials14Target SynonymCommon Cytokine Receptor Gamma Chain,IL-2R Subunit Gamma,IL2RG,SCIDX,CD132,CIDX,IL-2RG,IMD4,Nonfunctional Common Cytokine Receptor Gamma Chain,Combined Immunodeficiency, X-Linked,Interleukin 2 Receptor Subunit Gamma,Interleukin-2 Receptor Subunit Gamma,Severe Combined Immunodeficiency,Cytokine Receptor Common Subunit Gamma,CD132 Antigen,GammaC,Interleukin 2 Receptor, Gamma,IL-2 Receptor Subunit Gamma,SCIDX1,P64
Highest Development StagePhase 2 Clinical
English NameInterleukin-2 receptor subunit gamma
Target SynonymCommon Cytokine Receptor Gamma Chain,IL-2R Subunit Gamma,IL2RG,SCIDX,CD132,CIDX,IL-2RG,IMD4,Nonfunctional Common Cytokine Receptor Gamma Chain,Combined Immunodeficiency, X-Linked,Interleukin 2 Receptor Subunit Gamma,Interleukin-2 Receptor Subunit Gamma,Severe Combined Immunodeficiency,Cytokine Receptor Common Subunit Gamma,CD132 Antigen,GammaC,Interleukin 2 Receptor, Gamma,IL-2 Receptor Subunit Gamma,SCIDX1,P64
Approved Drugs0
Drugs in Clinical Trials14
Highest Development StagePhase 2 Clinical

IL-2 R gamma Product List

  • Product Category

    Protein (7)

  • Product Status

    Launched (7)

  • Species

    Human (3)Mouse (2)Rhesus macaque (1)Cynomolgus (1)

  • Tag

    Fc Tag (1)His Tag & Avi Tag (2)His Tag (4)

  • Conjugate

    Unconjugated (5)Biotin-labeled (2)

IL-2 R gamma Background

IL-2R is a heterotrimeric protein binds and responds to the cytokine IL-2. Three distinct chains of IL-2R, termed as α, β and γ, which are non-covalently associated are identified. The α and β chains are involved in binding IL-2, while signal transduction following cytokine interaction is carried out by the γ chain, along with the β subunit. The α chain of the IL-2R can bind to the β chain before receptor interaction with IL-2. The γ chain alone has a very weak affinity for IL-2, but after the ligand is bound to the α/β heterodimer, the γ chain becomes recruited to the complex to form a very stable macromolecular quaternary ligand/receptor complex. Interleukin-2 receptor subunit gamma (IL2RG), also known as cytokine receptor common subunit gamma, CD antigen CD132, gammaC, p64, which belongs to the type I cytokine receptor family or type 5 subfamily. IL2RG is located on the surface of immature blood-forming cells in bone marrow. Defects in IL2RG are the cause of severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID).

IL-2 R gamma Synonyms

IL2RG,CD132,CIDX,IMD4,P64,SCIDX,SCIDX1,gammaC

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
MB-107IND-14570; MB-107Phase 2 ClinicalNational Heart, Lung And Blood Institute, National Institute Of Allergy And Infectious Diseases (Niaid), National Institute of Health, Islamabad, St. Jude Children'S Research HospitalImmunologic Deficiency Syndromes; X-Linked Combined Immunodeficiency Diseases
Details
AWT-020AWT020; AWT-020; JS213; JS-213Phase 2 ClinicalAnwita Biosciences IncAutoimmune Diseases of the Nervous System; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Lung Neoplasms; Melanoma; Neoplasms; Solid tumours
Details
GI-101SIM-323; SIM323; SIM0323; GI-101Phase 2 ClinicalGI Innovation IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Neoplasms; Solid tumours; Uterine Cervical Neoplasms
Details
MB-501MB501; MB-501Phase 2 ClinicalAscendis Pharma IncNeoplasms
Details
PegenzileukinIBI-127; THOR-707; SAR-444245Phase 2 ClinicalSynthorx IncCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Squamous Cell Carcinoma; Head and Neck Neoplasms; Hodgkin Disease; Intestinal Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma; Mesothelioma; Multiple Myeloma; Neoplasm Metastasis; Oropharyngeal Neoplasms; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms
Details
LTC-004LTC004; LTC-004Phase 2 ClinicalLeto Laboratories Co LtdColorectal Neoplasms; Neoplasms; Pancreatic Neoplasms; Sarcoma; Solid tumours
Details
TransCon IL-2 β/γPhase 2 ClinicalAscendis Pharma A/SCarcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Ovarian Neoplasms; Solid tumours
Details
TYF-IL-2Rg gene-modified autologous stem cells (Shenzhen Geno-Immune Medical Institute)Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteX-Linked Combined Immunodeficiency Diseases
Details
Simlukafusp alfaFAP-IL2v; RG-7461; aFAP-IL2v; RO-6874281; FAP-IL2v FPPhase 1 ClinicalF. Hoffmann-La Roche LtdBreast Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Head and Neck Neoplasms; Melanoma; Solid tumours; Uterine Cervical Neoplasms
Details
BJ-001(Boji Biomedical Technology)BJ-001Phase 1 ClinicalBoji Biomedical Technology (Hangzhou) Co LtdCommunicable Diseases; Neoplasm Metastasis; Solid tumours
Details
ex vivo IL2RG stem cell-based gene therapy (Genethon/University College London/Hannover Medical School)Phase 1 ClinicalGenethonSevere Combined Immunodeficiency
Details
PD 1-proIL-2v (Proviva Therapeutics)PTX-912Phase 1 ClinicalProviva Therapeutics IncNeoplasm Metastasis; Neoplasms; Solid tumours
Details
NL-201 (Neoleukin Therapeutics)NL-201Phase 1 ClinicalNeoleukin Therapeutics IncSolid tumours
Details
Recombinant human interleukin 15(Beijing Kawin)Phase 1 ClinicalBeijing Kawin Technology Share-Holding Co LtdSolid tumours
Details
  • Overview
  • Product List
  • Clinical Drug Information